Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348)

HKG:2348 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,158	905.83	811.68	577.74	730.99
Short-Term Investments	242.34	107	88.8	44.3	30.02
Trading Asset Securities	207.14	160.87	181.36	208.18	201.12
Cash & Short-Term Investments	1,608	1,174	1,082	830.22	962.12
Cash Growth	36.98%	8.49%	30.31%	-13.71%	-16.18%
Accounts Receivable	267.89	322	402.85	346.78	330.75
Other Receivables	-	-	-	20.8	-
Receivables	267.89	322	402.85	367.58	330.75
Inventory	308.24	211.11	241.75	203.48	246.03
Prepaid Expenses	7.38	13.4	14.99	15.5	9.75
Other Current Assets	11	-	2.58	94.26	0.07
Total Current Assets	2,202	1,720	1,744	1,511	1,549
Property, Plant & Equipment	1,228	1,217	1,301	1,143	781.95
Long-Term Investments	20	20	25.35	87.25	98.67
Goodwill	241.16	241.16	241.16	241.16	241.16
Other Intangible Assets	164.77	160.31	109.48	97.99	36.18
Long-Term Deferred Tax Assets	5.47	18.98	6.86	5.75	6.53
Long-Term Deferred Charges	136.16	128	185.54	189.03	170.54
Other Long-Term Assets	11.08	10.3	7.56	14.36	20
Total Assets	4,009	3,623	3,673	3,340	2,904
Accounts Payable	221.56	162.16	224.07	143.21	157.61
Accrued Expenses	99.34	108.27	171.28	156.94	125.79
Short-Term Debt	29.86	120.06	6.43	21.01	-
Current Portion of Leases	1.16	0.36	1.53	0.98	0.92
Current Income Taxes Payable	2.6	45.23	8.65	15.5	9.3
Current Unearned Revenue	32.73	17.9	29.66	14.45	8.47
Other Current Liabilities	167.35	214.96	490.43	345.01	177.81
Total Current Liabilities	554.6	668.94	932.06	697.1	479.91
Long-Term Leases	3.7	0.1	0.44	1.53	2.03
Long-Term Unearned Revenue	3.36	-	0.3	0.6	0.9
Long-Term Deferred Tax Liabilities	120.95	94.38	89.98	66.87	61.72
Other Long-Term Liabilities	-	-	-	175.6	175.6
Total Liabilities	682.61	763.43	1,023	941.7	720.14
Common Stock	80.53	80.46	80.39	80.37	81.07
Additional Paid-In Capital	105.95	104.41	103.09	102.7	100.18
Retained Earnings	3,102	2,649	2,436	2,174	1,940
Treasury Stock	-	-	-	-	-0.43
Comprehensive Income & Other	35.5	21.24	22.51	23.2	49.26
Total Common Equity	3,324	2,855	2,642	2,381	2,171
Minority Interest	2.4	4.58	7.91	17.15	13.09
Shareholders' Equity	3,327	2,859	2,650	2,398	2,184
Total Liabilities & Equity	4,009	3,623	3,673	3,340	2,904
Total Debt	34.72	120.53	8.41	23.52	2.95
Net Cash (Debt)	1,573	1,053	1,073	806.7	959.17
Net Cash Growth	49.36%	-1.89%	33.06%	-15.90%	3.35%
Net Cash Per Share	1.04	0.70	0.71	0.53	0.62
Filing Date Shares Outstanding	1,502	1,500	1,499	1,498	1,505
Total Common Shares Outstanding	1,502	1,500	1,499	1,498	1,505
Working Capital	1,648	1,051	811.94	813.93	1,069
Book Value Per Share	2.21	1.90	1.76	1.59	1.44
Tangible Book Value	2,918	2,453	2,291	2,042	1,893
Tangible Book Value Per Share	1.94	1.64	1.53	1.36	1.26
Buildings	788.38	584.74	531.28	243.42	309.25
Machinery	634.79	485.74	721.4	624.16	749.76
Construction In Progress	85.57	356.9	495.14	675.2	204.8
Leasehold Improvements	6.68	6.66	6.64	6.59	5.98

Updated Sep 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.